Genetic Variation of SARS Coronavirus in Beijing Hospital

Emerging Infectious Diseases

Volumn 10, Issue 5, 2004, Pages 789-794

  Xu, Dongping ^a   Zhang, Zheng ^a   Chu, Fuliang ^a   Li, Yonggang ^a   Jin, Lei ^a   Zhang, Lingxia ^a   Gao, George F ^b   Wang, Fu Sheng ^a  

^a BEIJING 302 HOSPITAL   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHINA; CLINICAL ARTICLE; EPIDEMIC; FECES CULTURE; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MALE; NONHUMAN; PLASMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SPUTUM CULTURE; THROAT CULTURE; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 2142709586     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1005.030875     Document Type: Article

References (23)

1. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
3. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-404.
4. Liang WN, Mi J, Information Branch Joint Leadership Group of SARS Prevention and Control in Beijing. Epidemiological features of severe acute respiratory syndrome in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 2003;24:1096-9.
5. Domingo E. Quasispecies and the development of new antiviral strategies. Prog Drug Res 2003;60:133-58.
6. Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Fleming JO, et al. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 1995;209:337-46.
7. Ruan YJ, Wei CL, Ee AL, Vega VB, Thoreau H, Su ST, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 2003;361:1779-85.
8. Tsui SK, Chim SS, Lo YM. Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. N Engl J Med 2003;349:187-8.
9. Hu LD, Zheng GY, Jiang HS, Xia Y, Zhang Y, Kong XY. Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene. Acta Pharmacol Sin 2003;24:741-5.
10. Li L, Wang Z, Lu Y, Bao Q, Chen S, Wu N, et al. Severe acute respiratory syndrome-associated coronavirus genotype and its characterization. Chin Med J (Engl) 2003;116:1288-92.
11. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63.
12. Wain-Hobson S. Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr Top Microbiol Immunol 1992;176:181-93.
13. Zhou XZ, Zhao M, Wang FS, Jiang TJ, Li YG, Nie WM, et al. Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area. Zhonghua Yi Xue Za Zhi 2003;83:1018-22.
14. Wang FS, Xu D. Study of characteristics and pathogenic mechanism of SARS coronavirus. Infect Dis Inform 2003;16:67-8.
15. PCR primers for SARS developed by WHO network laboratories [monograph on the Internet]. Geneva: World Health Organization. 2003 Apr 17. Available from: http://www.who.int/csr/sars/primers/en/
16. Qin ED, Zhu QY, Yu M, Fan B, Chang G, Si B, et al. A complete sequence and comparative analysis of a SARS-associated virus (isolate BJ01). Chinese Sci Bull 2003;48:941-8.
17. Domingo E, Baranowski E, Ruiz-Jarabo CM, Martin-Hernandez AM, Saiz JC, Escarmis C. Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis 1998;4:521-7.
18. Maekawa S, Enomoto N, Kurosaki M, Nagayama K, Marumo F, Sato C. Genetic changes in the interferon sensitivity determining region of hepatitis C virus during the natural course of chronic hepatitis C. J Med Virol 2000;61:303-10.
19. Yang OO, Sarkis PT, Ali A, Harlow JD, Brander C, Kalams SA, et al. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J Exp Med 2003;197:1365-75.
20. Pewe L, Wu GF, Barnett EM, Castro RF, Perlman S. Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease. Immunity 1996;5:253-62.
21. Williamson S. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol Biol Evol 2003;20:1318-25.
22. Luo Z, Weiss SR. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology 1998;244:483-94.
23. Crotty S, Maag D, Arnold JJ, Zhong W, Lau JY, Hong Z, et al. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat Med 2000;6:1375-9.